[6-[6-[5-[(2-amino-4,5-dihydro-1H-imidazol-5-yl)-hydroxymethyl]-8-[[2-amino-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-4,5-dihydroimidazol-4-yl]-hydroxymethyl]-11-(hydroxymethyl)-2-[(4-hydroxyphenyl)methyl]-3,6,9,12,15,18-hexaoxo-17-(1-phenylethyl)-1,4,7,10,13,16-hexazacyclooctadec-1-yl]-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-3,4,5-trihydroxyoxan-2-yl]methyl heptanoate

C61H90N12O26 — CID 87982471

IUPAC[6-[6-[5-[(2-amino-4,5-dihydro-1H-imidazol-5-yl)-hydroxymethyl]-8-[[2-amino-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-4,5-dihydroimidazol-4-yl]-hydroxymethyl]-11-(hydroxymethyl)-2-[(4-hydroxyphenyl)methyl]-3,6,9,12,15,18-hexaoxo-17-(1-phenylethyl)-1,4,7,10,13,16-hexazacyclooctadec-1-yl]-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-3,4,5-trihydroxyoxan-2-yl]methyl heptanoate
SMILESCCCCCCC(=O)OCC1OC(OC2C(CO)OC(N3C(=O)C(C(C)c4ccccc4)NC(=O)CNC(=O)C(CO)NC(=O)C(C(O)C4CN=C(N)N4C4OC(CO)C(O)C(O)C4O)NC(=O)C(C(O)C4CN=C(N)N4)NC(=O)C3Cc3ccc(O)cc3)C(O)C2O)C(O)C(O)C1O
InChIInChI=1S/C61H90N12O26/c1-3-4-5-9-12-37(79)95-24-35-44(83)46(85)50(89)59(98-35)99-51-34(23-76)97-57(49(88)47(51)86)72-31(17-26-13-15-28(77)16-14-26)53(91)70-39(41(80)29-18-65-60(62)68-29)55(93)71-40(42(81)32-19-66-61(63)73(32)58-48(87)45(84)43(82)33(22-75)96-58)54(92)67-30(21-74)52(90)64-20-36(78)69-38(56(72)94)25(2)27-10-7-6-8-11-27/h6-8,10-11,13-16,25,29-35,38-51,57-59,74-77,80-89H,3-5,9,12,17-24H2,1-2H3,(H2,63,66)(H,64,90)(H,67,92)(H,69,78)(H,70,91)(H,71,93)(H3,62,65,68)
InChIKeyQHUAMMLUWSKANG-UHFFFAOYSA-N
MW1407.45 g/mol
LogP-11.05
Rot. Bonds22

About [6-[6-[5-[(2-amino-4,5-dihydro-1H-imidazol-5-yl)-hydroxymethyl]-8-[[2-amino-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-4,5-dihydroimidazol-4-yl]-hydroxymethyl]-11-(hydroxymethyl)-2-[(4-hydroxyphenyl)methyl]-3,6,9,12,15,18-hexaoxo-17-(1-phenylethyl)-1,4,7,10,13,16-hexazacyclooctadec-1-yl]-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-3,4,5-trihydroxyoxan-2-yl]methyl heptanoate

[6-[6-[5-[(2-amino-4,5-dihydro-1H-imidazol-5-yl)-hydroxymethyl]-8-[[2-amino-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-4,5-dihydroimidazol-4-yl]-hydroxymethyl]-11-(hydroxymethyl)-2-[(4-hydroxyphenyl)methyl]-3,6,9,12,15,18-hexaoxo-17-(1-phenylethyl)-1,4,7,10,13,16-hexazacyclooctadec-1-yl]-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-3,4,5-trihydroxyoxan-2-yl]methyl heptanoate (PubChem CID 87982471) has the molecular formula C61H90N12O26 and a molecular weight of 1407.45 g/mol. Its IUPAC name is [6-[6-[5-[(2-amino-4,5-dihydro-1H-imidazol-5-yl)-hydroxymethyl]-8-[[2-amino-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-4,5-dihydroimidazol-4-yl]-hydroxymethyl]-11-(hydroxymethyl)-2-[(4-hydroxyphenyl)methyl]-3,6,9,12,15,18-hexaoxo-17-(1-phenylethyl)-1,4,7,10,13,16-hexazacyclooctadec-1-yl]-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-3,4,5-trihydroxyoxan-2-yl]methyl heptanoate.

Molecular Properties

Compound Name[6-[6-[5-[(2-amino-4,5-dihydro-1H-imidazol-5-yl)-hydroxymethyl]-8-[[2-amino-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-4,5-dihydroimidazol-4-yl]-hydroxymethyl]-11-(hydroxymethyl)-2-[(4-hydroxyphenyl)methyl]-3,6,9,12,15,18-hexaoxo-17-(1-phenylethyl)-1,4,7,10,13,16-hexazacyclooctadec-1-yl]-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-3,4,5-trihydroxyoxan-2-yl]methyl heptanoate
PubChem CID87982471
Molecular FormulaC61H90N12O26
Molecular Weight1407.45 g/mol
Exact Mass1406.61
IUPAC Name[6-[6-[5-[(2-amino-4,5-dihydro-1H-imidazol-5-yl)-hydroxymethyl]-8-[[2-amino-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-4,5-dihydroimidazol-4-yl]-hydroxymethyl]-11-(hydroxymethyl)-2-[(4-hydroxyphenyl)methyl]-3,6,9,12,15,18-hexaoxo-17-(1-phenylethyl)-1,4,7,10,13,16-hexazacyclooctadec-1-yl]-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-3,4,5-trihydroxyoxan-2-yl]methyl heptanoate
SMILESCCCCCCC(=O)OCC1OC(OC2C(CO)OC(N3C(=O)C(C(C)c4ccccc4)NC(=O)CNC(=O)C(CO)NC(=O)C(C(O)C4CN=C(N)N4C4OC(CO)C(O)C(O)C4O)NC(=O)C(C(O)C4CN=C(N)N4)NC(=O)C3Cc3ccc(O)cc3)C(O)C2O)C(O)C(O)C1O
InChIInChI=1S/C61H90N12O26/c1-3-4-5-9-12-37(79)95-24-35-44(83)46(85)50(89)59(98-35)99-51-34(23-76)97-57(49(88)47(51)86)72-31(17-26-13-15-28(77)16-14-26)53(91)70-39(41(80)29-18-65-60(62)68-29)55(93)71-40(42(81)32-19-66-61(63)73(32)58-48(87)45(84)43(82)33(22-75)96-58)54(92)67-30(21-74)52(90)64-20-36(78)69-38(56(72)94)25(2)27-10-7-6-8-11-27/h6-8,10-11,13-16,25,29-35,38-51,57-59,74-77,80-89H,3-5,9,12,17-24H2,1-2H3,(H2,63,66)(H,64,90)(H,67,92)(H,69,78)(H,70,91)(H,71,93)(H3,62,65,68)
InChIKeyQHUAMMLUWSKANG-UHFFFAOYSA-N
XLogP-11.05
TPSA604.28 Ų
H-Bond Donors22
H-Bond Acceptors32
Rotatable Bonds22
Heavy Atoms99
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001407.45
LogP ≤ 5-11.05
H-Bond Donors ≤ 522
H-Bond Acceptors ≤ 1032

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze [6-[6-[5-[(2-amino-4,5-dihydro-1H-imidazol-5-yl)-hydroxymethyl]-8-[[2-amino-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-4,5-dihydroimidazol-4-yl]-hydroxymethyl]-11-(hydroxymethyl)-2-[(4-hydroxyphenyl)methyl]-3,6,9,12,15,18-hexaoxo-17-(1-phenylethyl)-1,4,7,10,13,16-hexazacyclooctadec-1-yl]-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-3,4,5-trihydroxyoxan-2-yl]methyl heptanoate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of [6-[6-[5-[(2-amino-4,5-dihydro-1H-imidazol-5-yl)-hydroxymethyl]-8-[[2-amino-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-4,5-dihydroimidazol-4-yl]-hydroxymethyl]-11-(hydroxymethyl)-2-[(4-hydroxyphenyl)methyl]-3,6,9,12,15,18-hexaoxo-17-(1-phenylethyl)-1,4,7,10,13,16-hexazacyclooctadec-1-yl]-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-3,4,5-trihydroxyoxan-2-yl]methyl heptanoate?
The IUPAC name of [6-[6-[5-[(2-amino-4,5-dihydro-1H-imidazol-5-yl)-hydroxymethyl]-8-[[2-amino-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-4,5-dihydroimidazol-4-yl]-hydroxymethyl]-11-(hydroxymethyl)-2-[(4-hydroxyphenyl)methyl]-3,6,9,12,15,18-hexaoxo-17-(1-phenylethyl)-1,4,7,10,13,16-hexazacyclooctadec-1-yl]-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-3,4,5-trihydroxyoxan-2-yl]methyl heptanoate (CID 87982471) is [6-[6-[5-[(2-amino-4,5-dihydro-1H-imidazol-5-yl)-hydroxymethyl]-8-[[2-amino-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-4,5-dihydroimidazol-4-yl]-hydroxymethyl]-11-(hydroxymethyl)-2-[(4-hydroxyphenyl)methyl]-3,6,9,12,15,18-hexaoxo-17-(1-phenylethyl)-1,4,7,10,13,16-hexazacyclooctadec-1-yl]-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-3,4,5-trihydroxyoxan-2-yl]methyl heptanoate.
What is the SMILES notation for [6-[6-[5-[(2-amino-4,5-dihydro-1H-imidazol-5-yl)-hydroxymethyl]-8-[[2-amino-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-4,5-dihydroimidazol-4-yl]-hydroxymethyl]-11-(hydroxymethyl)-2-[(4-hydroxyphenyl)methyl]-3,6,9,12,15,18-hexaoxo-17-(1-phenylethyl)-1,4,7,10,13,16-hexazacyclooctadec-1-yl]-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-3,4,5-trihydroxyoxan-2-yl]methyl heptanoate?
The canonical SMILES for [6-[6-[5-[(2-amino-4,5-dihydro-1H-imidazol-5-yl)-hydroxymethyl]-8-[[2-amino-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-4,5-dihydroimidazol-4-yl]-hydroxymethyl]-11-(hydroxymethyl)-2-[(4-hydroxyphenyl)methyl]-3,6,9,12,15,18-hexaoxo-17-(1-phenylethyl)-1,4,7,10,13,16-hexazacyclooctadec-1-yl]-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-3,4,5-trihydroxyoxan-2-yl]methyl heptanoate is CCCCCCC(=O)OCC1OC(OC2C(CO)OC(N3C(=O)C(C(C)c4ccccc4)NC(=O)CNC(=O)C(CO)NC(=O)C(C(O)C4CN=C(N)N4C4OC(CO)C(O)C(O)C4O)NC(=O)C(C(O)C4CN=C(N)N4)NC(=O)C3Cc3ccc(O)cc3)C(O)C2O)C(O)C(O)C1O.
What is the InChIKey of [6-[6-[5-[(2-amino-4,5-dihydro-1H-imidazol-5-yl)-hydroxymethyl]-8-[[2-amino-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-4,5-dihydroimidazol-4-yl]-hydroxymethyl]-11-(hydroxymethyl)-2-[(4-hydroxyphenyl)methyl]-3,6,9,12,15,18-hexaoxo-17-(1-phenylethyl)-1,4,7,10,13,16-hexazacyclooctadec-1-yl]-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-3,4,5-trihydroxyoxan-2-yl]methyl heptanoate?
The InChIKey is QHUAMMLUWSKANG-UHFFFAOYSA-N. The full InChI is InChI=1S/C61H90N12O26/c1-3-4-5-9-12-37(79)95-24-35-44(83)46(85)50(89)59(98-35)99-51-34(23-76)97-57(49(88)47(51)86)72-31(17-26-13-15-28(77)16-14-26)53(91)70-39(41(80)29-18-65-60(62)68-29)55(93)71-40(42(81)32-19-66-61(63)73(32)58-48(87)45(84)43(82)33(22-75)96-58)54(92)67-30(21-74)52(90)64-20-36(78)69-38(56(72)94)25(2)27-10-7-6-8-11-27/h6-8,10-11,13-16,25,29-35,38-51,57-59,74-77,80-89H,3-5,9,12,17-24H2,1-2H3,(H2,63,66)(H,64,90)(H,67,92)(H,69,78)(H,70,91)(H,71,93)(H3,62,65,68).
What are the key properties of [6-[6-[5-[(2-amino-4,5-dihydro-1H-imidazol-5-yl)-hydroxymethyl]-8-[[2-amino-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-4,5-dihydroimidazol-4-yl]-hydroxymethyl]-11-(hydroxymethyl)-2-[(4-hydroxyphenyl)methyl]-3,6,9,12,15,18-hexaoxo-17-(1-phenylethyl)-1,4,7,10,13,16-hexazacyclooctadec-1-yl]-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-3,4,5-trihydroxyoxan-2-yl]methyl heptanoate?
[6-[6-[5-[(2-amino-4,5-dihydro-1H-imidazol-5-yl)-hydroxymethyl]-8-[[2-amino-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-4,5-dihydroimidazol-4-yl]-hydroxymethyl]-11-(hydroxymethyl)-2-[(4-hydroxyphenyl)methyl]-3,6,9,12,15,18-hexaoxo-17-(1-phenylethyl)-1,4,7,10,13,16-hexazacyclooctadec-1-yl]-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-3,4,5-trihydroxyoxan-2-yl]methyl heptanoate has a molecular weight of 1407.45 g/mol, XLogP of -11.05, 22 rotatable bonds, 22 hydrogen bond donors, and 32 hydrogen bond acceptors.
Where does this data come from?
All data for [6-[6-[5-[(2-amino-4,5-dihydro-1H-imidazol-5-yl)-hydroxymethyl]-8-[[2-amino-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-4,5-dihydroimidazol-4-yl]-hydroxymethyl]-11-(hydroxymethyl)-2-[(4-hydroxyphenyl)methyl]-3,6,9,12,15,18-hexaoxo-17-(1-phenylethyl)-1,4,7,10,13,16-hexazacyclooctadec-1-yl]-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-3,4,5-trihydroxyoxan-2-yl]methyl heptanoate is sourced from PubChem (CID 87982471), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).